University of Connecticut

Life Sciences / Diagnostics Executive

Provide advisory services to early-stage healthcare technology companies in the life sciences, in vitro diagnostic, and laboratory service segments. Consulting services include strategic development, business and financial planning, product definition and commercial readiness, and sales and marketing growth strategies.

Independent Consultant

Advisor

The Technology Development Fund (TDF) is managed by the Technology and Innovation Office (TIDO) and was launched in 2009 to advance the stage of development of promising BCH technologies and support their translation into new devices, diagnostic tests and therapeutics that can benefit BCH's patients and the broader public.

Boston Children's Hospital

External Advisory Board Member, Technology Development Fund

Wentworth Institute of Technology (WIT) is a leading engineering, technology, and construction management university with a mission to empower, inspire and innovate through experiential learning.

Wentworth Institute of Technology

Board of Trustees

Appointed President & COO of newly acquired company; improved profitability 114% over three year period increasing operating income from 4% of revenues in 2011 to 9% of revenues in 2013.

-- Asked by executive leadership of Sekisui Chemical, a $10B Tokyo, Japan based company, to lead and transition the acquired diagnostics business from Genzyme Corporation into a newly formed Sekisui Diagnostics. 
-- Reported to the Chief Executive Officer of Sekisui Diagnostics with direct management responsibility for global R&D, manufacturing, sales and marketing, finance, human resources and legal affairs.  
-- Responsible for overseeing the day to day operating activities of Sekisui Diagnostics’ four legal entities located in the U.S., Canada, England and Germany and for executing business strategies in order to meet financial objectives.

Sekisui Diagnostics, LLC

President & Chief Operating Officer

Drove the transformation of the Diagnostics Division from a $20M supplier of raw materials to a $175M diversified, fully finished in vitro diagnostics business; grew business unit at a 8% CAGR over 15 year period.

-- Responsible for the direction and execution of the diagnostic business’ commercial strategy as well as leadership of a 100 person sales and marketing organization on a worldwide basis. 
-- Directed the business development activities in order to pursue new internal and acquired growth opportunities consistent with the defined strategic plan.

Sanofi Genzyme

Senior Vice President, Sales and Marketing, Diagnostics

Expanded and enhanced our strategic position in the niche business-to-business market through licensing partnerships with key suppliers and distributors.

-- Oversaw the formulation of tactical plans and allocation of resources in order to achieve annual revenue and profit objectives.
-- Interfaced with R&D, Operations and Finance senior managers to ensure appropriate cross-functional integration and prioritization.

Vice President, Sales and Marketing, Diagnostics

Redefined and implemented diversified product and distribution channel strategies to support short and long term market penetration goals.

-- Led and managed a marketing team comprised of five product managers and two technical marketing representatives for the finished in vitro diagnostic reagent and critical raw materials product lines. 
--Fostered collaborative relationships with peers in sales, operations and R&D to continually review progress against commercialization plans and make necessary adjustments.

Director of Marketing, Diagnostics Division

Launched and commercialized the first, direct LDL cholesterol test; reaching annual sales of >$5M in second year of launch; eventually building a >$40M LDL/HDL portfolio and #1 market share position.  

-- Obtained favorable reimbursement coverage and payment from Medicare and private insurance companies for LDL cholesterol testing. 
-- Established the technical marketing function within the Diagnostics Division to enhance product support for all customers.

Marketing Manager, Diagnostics

Established the product management function within the Diagnostics Division. Defined and implemented the business strategy for a new cardiovascular diagnostics product line.

Product Manager, Diagnostics Division

Licensed as a registered representative with the National Association of Securities Dealers and managed institutional fixed income accounts through both product generation (banks) and product sales (institutional investors).

Assistant Vice President, Fixed Income

Developed and implemented tactical market action plans to support and direct territory sales representatives in achieving sales objectives for the diagnostic product line. Established standards for the sales district, provided new product training to sales representatives, and formulated strategies to effectively address competitors' products.

Abbott

Diagnostic Product Specialist

Managed a sales territory of thirty-five accounts, both new and established, through initial contact, determination of goals, development of needs, and the installation of analytical systems and diagnostic products. Achieved President’s Club status for exceeding 100% of budget for all product groups and sales territory.

Jerry Casey